AMGN Amgen Earnings and EPS analysis

EPS in 2025 (TTM): $11.05

Last Report Period Date: Mar 31, 2025

As of May 2025, AMGN's current EPS stands at $11.05, according to the latest financial reports. For the year 2024, the company recorded an earnings per share (EPS) of $7.62, which marks a drop compared to its EPS of $12.56 in 2023. AMGN reported an EPS of $3.22 for the quarterly report ending on Mar 31, 2025.

For 2024, Amgen's EPS was $7.62, a drop of 39.3% from $12.56 in 2023. For the fiscal quarter that ended on Mar 31, 2025, the per-share earnings was $3.22, showing a 1,633.3% increase from the same quarter last year. For the twelve months ending March 2025, the EPS is $11.05. For the year 2023, the yearly earnings per share was $12.56, marking an increase of 3.1% from 2022.

Amgen has registered an increase in EPS of 1,633.3% during the last 12 months (YoY, quarterly). Examining a broader timeline, the company maintained an average EPS growth rate of -9.7% per year for the last three years. Amgen had an average annual EPS growth rate of -10.1% during the last 5 years. A 10-year view shows that AMGN has seen an average EPS growth of 1.1% per year.